Trial intelligence / Profile preview

Dioctyl sodium sulfosuccinate otic solution for preoperative umbilical dirt removal

jRCTs031200058Completed

Sponsor
CEOLIA Pharma
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of docusate sodium (4 arms), sponsored by CEOLIA Pharma. Primary endpoint: Removal effect of navel dirt. Started Jul 2020; status: completed.

02

Drugs

docusate sodium

Beyond the preview

Go deeper on jRCTs031200058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031200058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call